Development and validation of a nomogram for predicting survival in patients with cardiogenic shock
The CSSN was developed to predict 30-day survival rates in CS patients irrespective of the underlying cause, showing good performance and potential clinical utility in managing CS.
Authors
- Hui Geng (ORCID: https://orcid.org/0000-0003-3576-7933)
- Dingfeng Fang (ORCID: https://orcid.org/0000-0002-1190-668X)
- Xiahuan Chen (ORCID: https://orcid.org/0000-0003-3363-4942)
- Meilin Liu (ORCID: https://orcid.org/0000-0001-7580-8117)
- Huihe Chen
Institutions
- Peking University (CN)
- The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
- Peking University First Hospital (CN)
- Riverside Hospital of Guangxi Zhuang Autonomous Region (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-04-29
- DOI
- https://doi.org/10.3389/fcvm.2025.1538395
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00